Panacea Index Logo

Command Palette

Search for a command to run...

Psychological and behavioural interventions in bipolar disorder that target sleep and circadian rhythms: A systematic review of randomised controlled trials.

Neuroscience and biobehavioral reviews
January 1, 2022
Lampros Bisdounis et al. (7 authors)
Journal ArticleMeta-AnalysisResearch Support, Non-U.S. Gov'tReviewSystematic ReviewHuman Study
Extracted Claims (1)
InterventionDirectionEndpointPopulationDosageImpactClaim #
bright light therapy
decrease
depression
-
g=-0.74 [95 % CI=-1.05 to -0.42]
revealing a medium-to-large post-treatment effect
#1
Abstract

Sleep and circadian disruptions are prominent symptoms of bipolar disorder (BD) and potential targets for adjunctive interventions. The aim of this review was to appraise the effectiveness of psychological and behavioural interventions in BD that target sleep and circadian rhythms, as reported by randomised controlled trials. Nineteen studies met the inclusion/exclusion criteria. They were summarised via narrative synthesis and meta-analysis wherever appropriate. Six studies delivered bright light therapy, five interpersonal and social rhythm therapy, two blue-light blocking glasses, one cognitive behavioural therapy for insomnia, one total sleep deprivation, and four combination treatments. More than half of the studies (N = 10, 52 %) did not measure sleep or circadian rhythms despite being the principal target of the intervention. Overall, the evidence base for the effectiveness of these interventions was limited. There was a small number of studies for each intervention, and a lack of consistency in protocols and outcomes. Meta-analysis was possible for the effect of bright light therapy on depression, revealing a medium-to-large post-treatment effect (Nc = 6; g=-0.74 [95 % CI=-1.05 to -0.42], p < 0.001).

Medical Subject Headings (MeSH)
Bipolar DisorderCircadian RhythmHumansPhototherapySleepSleep Deprivation
Study Links
Citation Metrics
Total Citations14
Citations/Year4.7
Relative Citation Ratio2.24
NIH Percentile77.8%
Research Impact Scores
APT Score0.50
Related Supplements